Publications by authors named "Shigeki Arii"

Claim this Profile
S
Simplified risk stratification in early cholecystectomy for acute cholecystitis based on age: A report from an institution with zero mortality.
Yugo Matsui, Siyuan Yao, Kana Ishikawa, Shusaku Homma, Shinichi Hosokawa, Shigeki Arii

J Hepatobiliary Pancreat Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgeons' involvement in COVID-19 treatment: a practice by a regional core hospital in Japan to avoid physician burnout.
Yugo Matsui, Siyuan Yao, Takashi Kumode, Keisuke Tanino, Ryosuke Mizuno, Shigeki Arii

BMC Health Serv Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety and feasibility of laparoscopic gastrectomy for gastric cancer in very elderly patients: short-and long-term outcomes.
Ryuichi Mikami, Eiji Tanaka, Teppei Murakami, Satoshi Ishida, Yugo Matsui, Shigeki Arii

Surg Today· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive molecular and immunological characterization of hepatocellular carcinoma.
Shu Shimada, Kaoru Mogushi, Yoshimitsu Akiyama, Takaki Furuyama, Shuichi Watanabe, Shigeki Arii

EBioMedicine· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors.
Norimichi Chiyonobu, Shu Shimada, Yoshimitsu Akiyama, Kaoru Mogushi, Michiko Itoh, Shigeki Arii

Am J Pathol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
Kenichi Takayasu, Shigeki Arii, Michiie Sakamoto, Yutaka Matsuyama, Masatoshi Kudo

Liver Int· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DEPDC5 deficiency contributes to resistance to leucine starvation via p62 accumulation in hepatocellular carcinoma.
Yuki Mizuno, Shu Shimada, Yoshimitsu Akiyama, Shuichi Watanabe, Tomomi Aida, Shigeki Arii

Sci Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired Resistance with Epigenetic Alterations Under Long-Term Antiangiogenic Therapy for Hepatocellular Carcinoma.
Yoshiteru Ohata, Shu Shimada, Yoshimitsu Akiyama, Kaoru Mogushi, Keisuke Nakao, Shigeki Arii

Mol Cancer Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factors.
Keiichi Akahoshi, Shinji Tanaka, Kaoru Mogushi, Shu Shimada, Satoshi Matsumura, Shigeki Arii

J Gastroenterol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dominant Expression of DCLK1 in Human Pancreatic Cancer Stem Cells Accelerates Tumor Invasion and Metastasis.
Hiromitsu Ito, Shinji Tanaka, Yoshimitsu Akiyama, Shu Shimada, Rama Adikrisna, Shigeki Arii

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteasome activity is required for the initiation of precancerous pancreatic lesions.
Takaki Furuyama, Shinji Tanaka, Shu Shimada, Yoshimitsu Akiyama, Satoshi Matsumura, Shigeki Arii

Sci Rep· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA methylation analysis in hepatocellular carcinoma.
Nobuhisa Yamada, Kohichiroh Yasui, Osamu Dohi, Yasuyuki Gen, Akira Tomie, Shigeki Arii

Oncol Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
Eriko Katsuta, Shinji Tanaka, Kaoru Mogushi, Shu Shimada, Yoshimitsu Akiyama, Shigeki Arii

Int J Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel therapeutic combination sequentially targeting aurora B and Bcl-xL in hepatocellular carcinoma.
Hiroko Matsunaga, Shinji Tanaka, Arihiro Aihara, Kousuke Ogawa, Satoshi Matsumura, Shigeki Arii

Ann Surg Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Aurora/vascular endothelial growth factor receptor dual kinase inhibitor as treatment for hepatocellular carcinoma.
Keisuke Nakao, Shinji Tanaka, Tomoya Miura, Kota Sato, Satoshi Matsumura, Shigeki Arii

Cancer Sci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
Kohichiroh Yasui, Chika Konishi, Yasuyuki Gen, Mio Endo, Osamu Dohi, Shigeki Arii

Cancer Sci· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA methylation at hepatitis B viral integrants is associated with methylation at flanking human genomic sequences.
Yoshiyuki Watanabe, Hiroyuki Yamamoto, Ritsuko Oikawa, Minoru Toyota, Masakazu Yamamoto, Shigeki Arii

Genome Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of Child-Pugh score 5 and 6 in hepatocellular carcinoma patients who underwent curative hepatic resection.
Chisato Okajima, Shigeki Arii, Shinji Tanaka, Satoshi Matsumura, Daisuke Ban

Am J Surg· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines).
Norihiro Kokudo, Kiyoshi Hasegawa, Masaaki Akahane, Hiroshi Igaki, Namiki Izumi, Shigeki Arii

Hepatol Res· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?
Atsushi Kudo, Satoshi Matsumura, Daisuke Ban, Takumi Irie, Takanori Ochiai, Shigeki Arii

Hepatol Res· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gd-EOB-DTPA-enhanced magnetic resonance imaging and alpha-fetoprotein predict prognosis of early-stage hepatocellular carcinoma.
Taro Yamashita, Azusa Kitao, Osamu Matsui, Takehiro Hayashi, Kouki Nio, Shigeki Arii

Hepatology· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related clinicopathologic and molecular features of patients receiving curative hepatectomy for hepatocellular carcinoma.
Eriko Katsuta, Shinji Tanaka, Kaoru Mogushi, Satoshi Matsumura, Daisuke Ban, Shigeki Arii

Am J Surg· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EpCAM-targeted therapy for human hepatocellular carcinoma.
Kousuke Ogawa, Shinji Tanaka, Satoshi Matsumura, Ayano Murakata, Daisuke Ban, Shigeki Arii

Ann Surg Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced organic anion transporter expression is a risk factor for hepatocellular carcinoma in chronic hepatitis C patients: a propensity score matching study.
Yutaka Yasui, Atsushi Kudo, Masayuki Kurosaki, Shuya Matsuda, Masaru Muraoka, Shigeki Arii

Oncology· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Curative resection of stage IV advanced gallbladder cancer following combined treatment with gemcitabine and CDDP].
Rama Adikrisna, Noriaki Nakamura, Takumi Irie, Satoshi Matsumura, Shinji Tanaka, Shigeki Arii

Gan To Kagaku Ryoho· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis